Diabetic nephropathy
- 1 April 1993
- journal article
- research article
- Published by Informa UK Limited in Postgraduate Medicine
- Vol. 93 (5), 89-100
- https://doi.org/10.1080/00325481.1993.11701662
Abstract
Preview Which patients with diabetes are at greatest risk for development of nephropathy? How can it be prevented or its course delayed? What role does proteinuria play in its progression? What factors must be considered in selecting antihypertensive agents for patients with diabetes? Dr Bakris addresses these and other questions.Keywords
This publication has 28 references indexed in Scilit:
- Long-term comparison between captopril and nifedipine in the progression of renal insufficiencyKidney International, 1992
- Short and long term effects of antihypertensive therapy in the diabetic ratKidney International, 1989
- Glomerular Lesions and Urinary Albumin Excretion in Type I Diabetes without Overt ProteinuriaNew England Journal of Medicine, 1989
- Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.BMJ, 1988
- Predisposition to Hypertension and Susceptibility to Renal Disease in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- Calciumantagonisten bei chronischer Niereninsuffizienz: Unerwünschte Effekte auf die glomeruläre Hämodynamik?Deutsche Medizinische Wochenschrift (1946), 1988
- Antihypertensive Treatment and Serum LipoproteinsJournal Of Hypertension, 1985
- Structural-functional relationships in diabetic nephropathy.JCI Insight, 1984
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984
- MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUSThe Lancet, 1982